Statistics
Publications
21
Citations
1.4K
H-Index
19
Active since
2002
Michele Mayo is an author at AstraZeneca (United States) specializing in oncology, pharmacology, and molecular oncology.
Publications per year
2002–2024
21
21
Antibody-Maytansinoid Conjugates Designed to Bypass Multidrug Resistance
Yelena Kovtun, Charlene A. Audette, Michele Mayo et al. · Cancer Research · 2010 · 259 citations
Medicine, Oncology, Pharmacology +16
A New Class of Antibody–Drug Conjugates with Potent DNA Alkylating Activity
Michael L. Miller, Nathan Fishkin, Wěi Li et al. · Molecular Cancer Therapeutics · 2016 · 101 citations
1–5 of 21